17β-estradiol induces up-regulation of PTEN and PPARγ in leiomyoma cells, but not in normal cells

International Journal of Oncology

Volumn 36, Issue 4, 2010, Pages 921-927

  Jeong, Young Ju ^a   Noh, Eun Mi ^a   Lee, Young Rae ^a   Yu, Hong Nu ^a   Jang, Kyu Yun ^a   Lee, Seung Jin ^b   Kim, Jonghyeon ^a   Kim, Jong Suk ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Estradiol; PPAR ; PTEN; Uterine leiomyoma

Indexed keywords

ESTRADIOL; ESTROGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE; POLYPHOSPHOINOSITIDE; PROTEIN KINASE B; PTEN PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MYOMETRIUM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; WESTERN BLOTTING; ADULT; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL CULTURE; UPREGULATION; UTERUS CANCER;

ADULT; BLOTTING, WESTERN; ESTRADIOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MIDDLE AGED; MYOMETRIUM; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORYLATION; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; UP-REGULATION; UTERINE NEOPLASMS;

EID: 77749299320     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000571     Document Type: Article

References (33)

1. Li DM and Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57: 2124-2129, 1997.
2. Steck PA, Pershouse MA and Jasser SA: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362, 1997.
3. Eng C, Stratton M and Ponder B: Familial cancer syndromes. Lancet 343: 709-713, 1994.
4. Garcia JM, Silva JM and Dominguez G: Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype. Breast Cancer Res Treat 57: 237-243, 1999.
5. Liaw D, Marsh DJ and Li J: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16: 64-67, 1997.
6. Vivanco I and Sawyers CL: The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501, 2002.
7. Weng LP, Brown JL and Eng C: PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum Mol Genet 10: 599-604, 2001.
8. Eng C and Peacocke M: PTEN and inherited hamartoma-cancer syndromes. Nat Genet 19: 223, 1998.
9. Kim KY, Kim SS and Cheon HG: Differential anti-proliferative actions of peroxisome proliferator-activated receptor-gamma agonists in MCF-7 breast cancer cells. Biochem Pharmacol 72: 530-540, 2006.
10. Buttram VC Jr and Reiter RC: Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 36: 433-445, 1981.
11. Cramer SF, Marchetti C, Freedman J and Padela A: Relationship of myoma cell size and menopausal status in small uterine leiomyomas. Arch Pathol Lab Med 124: 1448-1453, 2000.
12. Chiaffarino F, Parazzini F, La Vecchia C, Chatenoud L, Di Cintio E and Marsico S: Diet and uterine myomas. Obstet Gynecol 94: 395-398, 1999.
13. Chiaffarino F, Parazzini F, La Vecchia C, Marsico S, Surace M and Ricci E: Use of oral contraceptives and uterine fibroids: results from a case-control study. Br J Obstet Gynaecol 106: 857-860, 1999.
14. Chiaffarino F, Parazzini F, La Vecchia C, Ricci E and Crosignani PG: Oral contraceptive use and benign gynecologic conditions. A review. Contraception 57: 11-18, 1998.
15. Clemons M and Goss P: Estrogen and the risk of breast cancer. N Engl J Med 344: 276-285, 2001.
16. Ikeda K and Inoue S: Estrogen receptors and their downstream targets in cancer. Arch Histol Cytol 67: 435-442, 2004.
17. Marshall LM, Spiegelman D and Barbieri RL: Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 90: 967-973, 1997.
18. Marshall LM, Spiegelman D and Goldman MB: A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 70: 432-439, 1998.
19. Marshall LM, Spiegelman D and Manson JE: Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology 9: 511-517, 1998.
20. Parazzini F, Negri E, La Vecchia C, Chatenoud L, Ricci E and Guarnerio P: Reproductive factors and risk of uterine fibroids. Epidemiology 7: 440-442, 1996.
21. Parazzini F, Negri E, La Vecchia C, Fedele L, Rabaiotti M and Luchini L: Oral contraceptive use and risk of uterine fibroids. Obstet Gynecol 79: 430-433, 1992.
22. Parazzini F, Negri E and La Vecchia C: Uterine myomas and smoking. Results from an Italian study. J Reprod Med 41: 316-320, 1996.
23. Adamson GD: Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists. Am J Obstet Gynecol 166: 746-751, 1992.
24. Gao Z, Matsuo H, Wang Y, Nakago S and Maruo T: Upregulation by IGF-I of proliferating cell nuclear antigen and Bcl-2 protein expression in human uterine leiomyoma cells. J Clin Endocrinol Metab 86: 5593-5599, 2001.
25. Guzeloglu-Kayisli O, Kayisli UA, Al-Rejjal R, Zheng W, Luleci G and Arici A: Regulation of PTEN (phosphatase and tensin homolog deleted on chromosome 10) expression by estradiol and progesterone in human endometrium. J Clin Endocrinol Metab 88: 5017-5026, 2003.
26. Mutter GL, Lin MC, Fitzgerald JT, Kum JB and Eng C: Changes in endometrial PTEN expression throughout the human menstrual cycle. J Clin Endocrinol Metab 85: 2334-2338, 2000.
27. Niswender KD, Gallis B, Blevins JE, Corson MA, Schwartz MW and Baskin DG: Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin. J Histochem Cytochem 51: 275-283, 2003.
28. Gericke A, Munson M and Ross AH: Regulation of the PTEN phosphatase. Gene 374: 1-9, 2006.
29. Vazquez F, Grossman SR, Takahashi Y, Rokas MV, Nakamura N and Sellers WR: Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J Biol Chem 276: 48627-48630, 2001.
30. Myers MP, Pass I and Batty IH: The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 95: 13513-13518, 1998.
31. Rosen ED and Spiegelman BM: PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276: 37731-37734, 2001.
32. Koeffler HP: Peroxisome proliferator-activated receptor gamma and cancers. Clin Cancer Res 9: 1-9, 2003.
33. Patel L, Pass I, Coxoo P, Downes CP, Smith SA and Macphee CH: Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr Biol 11: 764-768, 2001.